Gene · 8106
Papers1,471
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,471
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2. | Nucleic Acids Res | 2023 | 37414542 | PubTator, text mining | PubMed |
| Regulation of Atp7a RNA contributes to differentiation-dependent Cu redistribution in skeletal muscle cells. | Metallomics | 2023 | 37391383 | PubTator, text mining | PubMed |
| Characterizing alternative splicing effects on protein interaction networks with LINDA. | Bioinformatics | 2023 | 37387163 | PubTator, text mining | PubMed |
| Novel Metabolomic Approach for Identifying Pathology-Specific Biomarkers in Rare Diseases: A Case Study in Oculopharyngeal Muscular Dystrophy (OPMD). | Metabolites | 2023 | 37367926 | PubTator, text mining | PubMed |
| The RNA-binding protein ZC3H11A interacts with the nuclear poly(A)-binding protein PABPN1 and alters polyadenylation of viral transcripts. | J Biol Chem | 2023 | 37356722 | Swiss-Prot, curated | PubMed |
| Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment. | BMC Neurol | 2023 | 37328820 | PubTator, text mining | PubMed |
| Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer. | Aging (Albany NY) | 2023 | 37319315 | PubTator, text mining | PubMed |
| Poly(A)-binding protein is an ataxin-2 chaperone that regulates biomolecular condensates. | Mol Cell | 2023 | 37295429 | PubTator, text mining | PubMed |
| Extension of mRNA poly(A) tails and 3'UTRs during neuronal differentiation exhibits variable association with post-transcriptional dynamics. | Nucleic Acids Res | 2023 | 37293985 | PubTator, text mining | PubMed |
| Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders. | Front Neurol | 2023 | 37273706 | PubTator, text mining | PubMed |
| Ablation of ZC3H11A causes early embryonic lethality and dysregulation of metabolic processes. | Proc Natl Acad Sci U S A | 2023 | 37252988 | PubTator, text mining | PubMed |
| Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps. | Nat Methods | 2023 | 37248388 | PubTator, text mining | PubMed |
| Advances in deciphering the interactions between viral proteins of influenza A virus and host cellular proteins. | Cell Insight | 2023 | 37193064 | PubTator, text mining | PubMed |
| Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders. | J Neuromuscul Dis | 2023 | 37182896 | PubTator, text mining | PubMed |
| Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma. | Transl Androl Urol | 2023 | 37181233 | PubTator, text mining | PubMed |
| Protein Aggregates and Aggrephagy in Myopathies. | Int J Mol Sci | 2023 | 37176163 | PubTator, text mining | PubMed |
| An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus. | Nat Cell Biol | 2023 | 37156909 | PubTator, text mining | PubMed |
| The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. | Front Pharmacol | 2023 | 37153758 | PubTator, text mining | PubMed |
| Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer. | Front Genet | 2023 | 37124622 | PubTator, text mining | PubMed |
| m6A readers ECT2/ECT3/ECT4 enhance mRNA stability through direct recruitment of the poly(A) binding proteins in Arabidopsis. | Genome Biol | 2023 | 37122016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8106/papers?page=7